Current Neuro-Oncology

Volume 25 Number 11
15 June 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 11, 15 June

Fujii K, Hirano S, Kurozumi K, Date I.
A Case of High-Grade Glioma in an Eloquent Area Treated with Awake Craniotomy in an 85-year-old Patient.
Acta Med Okayama. 2023 Jun;77(3):335-340. doi: 10.18926/AMO/65504. PMID: 37357636. Case report. ˍ

Boroun A, Gholamhosseinian H, Montazerabadi A, Molana SH, Pashaei F.
Optimizing the Radiation Treatment Planning of Brain Tumors by Integration of Functional MRI and White Matter Tractography.
J Biomed Phys Eng. 2023 Jun 1;13(3):239-250. doi: 10.31661/jbpe.v0i0.2210-1547? PMID: 37312891. Observational study. ˍ

Christ SM, Willmann J, Heesen P, Kühnis A, Tanadini-Lang S, Looman EL, Ahmadsei M, Blum D, Guckenberger M, Balermpas P, Hertler C, Andratschke N.
Mortality during or shortly after Curative-Intent Radio-(Chemo-)Therapy over the last decade at a large comprehensive cancer center.
Clin Transl Radiat Oncol. 2023 Jun 1;41:100645. doi: 10.1016/j.ctro.2023.100645. PMID: 37304171. Observational study. ˍ

Caccese M, Desideri I, Padovan M, Bruno F, Cerretti G, Fiorentino A, Denaro L, Chioffi F, Della Puppa A, Maccari M, Cavallin F, Coppola M, Pittaro A, Rudà R, Livi L, Lombardi G.
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study.
J Neurooncol. 2023 Jun 1. doi: 10.1007/s11060-023-04356-w. PMID: 37264256. Observational study. ˍ

Eltoukhy M, Kandula V, Joseph S, Albanese E, Giridharan S.
"Should Redo Surgery be Offered to Patients with Relapsed Glioblastoma? - Outcome analyses of a single institution comparative cohort study".
World Neurosurg. 2023 Jun 1:S1878-8750(23)00729-5. doi: 10.1016/j.wneu.2023.05.097. PMID: 37268188. Observational study˰ ˍ


Garcez PP, Guasti A, Ventura N, Higa LM, Andreiuolo F, de Freitas GPA, Ribeiro LJ, Maia RA, de Lima SMB, de Souza Azevedo A, Schwarcz WD, Caride EC, Chimelli L, Dubois LG, Ferreira Júnior ODC, Tanuri A, Moura-Neto V, Niemeyer P.
Case report: Regression of Glioblastoma after flavivirus infection.
Front Med (Lausanne). 2023 Jun 1;10:1192070. doi: 10.3389/fmed.2023.1192070. PMID: 37324152. Case report. ˍ

Shafizadeh M, Farzaneh F, Kankam SB, Jangholi E, Shafizadeh Y, Khoshnevisan A.
Effects of postoperative intravenous Cyclosporine treatement on the survival and functional performance status of patients with glioblastoma: A randomized, triple-blinded, placebo-controlled clinical trial.
World Neurosurg. 2023 Jun 1:S1878-8750(23)00733-7. doi: 10.1016/j.wneu.2023.05.101. PMID: 37268192. Interventional study˰ ˍ

Yang W, Ma W, Huang J, Cai Y, Peng X, Zhao F, Zhang D, Zou Z, Sun H, Qi X, Ge M.
Beijing Children's Hospital guidelines on the design and conduction of the first standardized database for medulloblastoma.
Metab Brain Dis. 2023 Jun 1. doi: 10.1007/s11011-023-01233-3. PMID: 37261631. Observational study˰ ˍ

Aleid AM, Alaethan MH, Alsaati AA, Alhejji MH, Ali Alkathem J.
Medullary brainstem gliomas in an adult: A rare case report and challenging tumor.
Surg Neurol Int. 2023 Jun 2;14:190. doi: 10.25259/SNI_189_2023. PMID: 37404499. Case report. ˍ

Früh A, Schaumann A, Cohrs G, Pennacchietti V, Schulz M, Hernáiz Driever P, Koch A, Thomale UW.
Biopsies of caudal brainstem tumors in pediatric patients - a single center retrospective case series.
World Neurosurg. 2023 Jun 2:S1878-8750(23)00754-4. doi: 10.1016/j.wneu.2023.05.108. PMID: 37271255. Observational study˰ ˍ

Xi C, Jinli S, Jianyao M, Yan C, Huijuan L, Zhongjie S, Zhangyu L, Liwei Z, Yukui L, Sifang C, Guowei T.
Fluorescein-guided surgery for high-grade glioma resection: a five-year-long retrospective study at our institute.
Front Oncol. 2023 Jun 2;13:1191470. doi: 10.3389/fonc.2023.1191470. PMID: 37333818. Observational study. ˍ

Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F, Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y, Sepulveda JM, Wick W, Soffietti R, Perry JR, Giglio P, de la Fuente M, Maher EA, Schoenfeld S, Zhao D, Pandya SS, Steelman L, Hassan I, Wen PY, Cloughesy TF.
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
N Engl J Med. 2023 Jun 4. doi: 10.1056/NEJMoa2304194. PMID: 37272516. Interventional study. ˍ


Fine H, Reid T, Caroen S, Oronsky B, Abrouk N, Butowski N.
A multicenter, phase 1, dose escalation clinical trial (G-FORCE-1) of XRT, RRx-001 and temozolomide followed by temozolomide +/- RRx-001 in newly diagnosed glioblastoma.
Front Oncol. 2023 Jun 5;13:1176448. doi: 10.3389/fonc.2023.1176448. PMID: 37342189. Interventional study. ˍ

Robles-Castro J, Niembro-Zúñiga A, Ortiz-Azpilcueta M, Betanzos-Cabrera Y, Arreguín-González F, Barrera-Villegas G, Ortiz-Morales D, Arroyo-Acosta JB, Zapata-Tarrés M.
Diffuse intrinsic pontine gliomas: First registry effort in Mexico.
Pediatr Blood Cancer. 2023 Jun 5:e30431. doi: 10.1002/pbc.30431. PMID: 37277314. Observational study˰ ˍ

Yoon WS, Chang JH, Kim JH, Kim YJ, Jung TY, Yoo H, Kim SH, Ko YC, Nam DH, Kim TM, Kim SH, Park SH, Lee YS, Yim HW, Hong YK, Yang SH.
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study).
Discov Oncol. 2023 Jun 6;14(1):90. doi: 10.1007/s12672-023-00678-3. PMID: 37278858. Interventional study. ˍ

Weller J, Katzendobler S, Niedermeyer S, Harter PN, Herms J, Trumm C, Niyazi M, Thon N, Tonn JC, Stoecklein VM.
Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status.
J Neurooncol. 2023 Jun 8. doi: 10.1007/s11060-023-04362-y. PMID: 37289281. Observational study. ˍ

You WC, Lee HD, Pan HC, Chen HC.
Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors.
Sci Rep. 2023 Jun 9;13(1):9442. doi: 10.1038/s41598-023-36290-2. PMID: 37296207. Observational study. ˍ

Ehret F, Wolfgang J, Allwohn L, Onken J, Wasilewski D, Roohani S, Oertel J, Zips D, Kaul D.
Outcomes of Isocitrate Dehydrogenase Wild Type Glioblastoma after Re-irradiation.
Clin Transl Radiat Oncol. 2023 Jun 13;42:100653. doi: 10.1016/j.ctro.2023.100653. PMID: 37502699. Observational study. ˍ

Gong X, Kuang S, Deng D, Wu J, Zhang L, Liu C.
Differences in survival prognosticators between children and adults with H3K27M-mutant diffuse midline glioma.
CNS Neurosci Ther. 2023 Jun 13. doi: 10.1111/cns.14307. PMID: 37311690. Observational study. ˍ

Liu H, Sun P.
A Nomogram Model for Predicting Prognosis of Patients with Medulloblastoma.
Turk Neurosurg. 2023 Jun 13. doi: 10.5137/1019-5149.JTN.40397-22.3? PMID: 37309623. Observational study. ˍ

Sandler CX, Gildea GC, Spence RR, Jones TL, Eliadis P, Walker D, Donaghue A, Bettington C, Keller J, Pickersgill D, Shevill M, Biggs V, Morrison B, Jonker F, Foote M, Bashford J, Hayes SC.
The safety, feasibility, and efficacy of an 18-week exercise intervention for adults with primary brain cancer - the BRACE study.
Disabil Rehabil. 2023 Jun 13:1-10. doi: 10.1080/09638288.2023.2221041. PMID: 37310040. Interventional study˰ ˍ

McClelland S 3rd, Sun Y, Spratt DE.
Spine Patient Optimal Radiosurgery Treatment for Symptomatic Metastatic Neoplasms (SPORTSMEN): a randomized phase II study protocol.
Rep Pract Oncol Radiother. 2023 Jun 14;28(3):379-388. doi: 10.5603/RPOR.a2023.0037. PMID: 37795393. Interventional study protocol. ˍ

Delacourt L, Allodji R, Chappat J, Haddy N, El-Fayech C, Demoor-Goldschmidt C, Journy N, Bolle S, Thomas-Teinturier C, Zidane M, Rubino C, Veres C, Vu-Bezin G, Berchery D, Pluchart C, Bondiau PY, Dumas A, Bougas N, Grill J, Dufour C, Fresneau B, Pacquement H, Diallo I, Doz F, de Vathaire F.
Risk factors for obesity in adulthood among survivors of childhood cancer.
Obesity (Silver Spring). 2023 Jun 15. doi: 10.1002/oby.23784. PMID: 37318080. Observational study˰ ˍ


La Rosa A, Gutierrez AN, Odia Y, McDermott MW, Ahluwalia MS, Mehta MP, Kotecha R.
Temporally modulated pulsed proton re-irradiation (TMPPR) for recurrent high-grade gliomas.
Neurooncol Adv. 2023 Jun 15;5(1):vdad074. doi: 10.1093/noajnl/vdad074. PMID: 37358937. Case report. ˍ

Mueller S, Kline C, Stoller S, Lundy S, Christopher L, Reddy AT, Banerjee A, Cooney TM, Raber S, Hoffman C, Luks T, Wembacher-Schroeder E, Lummel N, Zhang Y, Bonner ER, Nazarian J, Molinaro AM, Prados M, Villanueva-Meyer JE, Gupta N.
PNOC015: Repeated convection enhanced delivery (CED) of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
Neuro Oncol. 2023 Jun 15:noad105. doi: 10.1093/neuonc/noad105. PMID: 37318058. Interventional study˰ ˍ

Rameh V, Vajapeyam S, Ziaei A, Kao P, London WB, Baker SJ, Chiang J, Lucas J, Tinkle CL, Wright KD, Poussaint TY.
Correlation between Multiparametric MR Imaging and Molecular Genetics in Pontine Pediatric High-Grade Glioma.
AJNR Am J Neuroradiol. 2023 Jun 15. doi: 10.3174/ajnr.A7910. PMID: 37321859. Observational study. ˍ